EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   2.3.1.67 | -999 |
- |
- |
487376, 487393 |
| 2.3.1.67 | -999 |
- |
exogenous addition of lyso-platelet-activating factor (PAF) without effect on acetyltransferase activity, block of enzyme activity by a tyrosine kinase inhibitor and a calmodulin antagonist in H2O2-stimulated cells suggests involvement of tyrosine kinase and calcium/calmodulin-dependent protein kinase in regulation of enzyme activity |
672495 |
| 2.3.1.67 | -999 |
- |
influence of phospholipids on specific activity at 37°C |
487381 |
| 2.3.1.67 | -999 |
- |
specific activity of 32.4%, 1.7 ng/microl Tenofovir-DF in the cell incubation medium of HMC |
701601 |
| 2.3.1.67 | -999 |
- |
specific activity of 76.2%, 1.9 ng/microl Lopinavir-r in the cell incubation medium of HMC |
701601 |
| 2.3.1.67 | -999 |
- |
transcript level and enzyme activity elevated in spinal cord of experimental allergic encephalomyelitis (EAE) mice, correlation with disease severity, accumulation of platelet-activating factor dependent on the group IVA cytosolic PLA2/LysoPAFAT present in infiltrating macrophages and activated microglia |
688161 |
| 2.3.1.67 | 0.0000041 |
- |
median activity of lyso-PAF-acetyltransferase in leukocyte homogenates of patients with heart failure |
703250 |
| 2.3.1.67 | 0.000017 |
- |
brain, Ca2+ independent lyso-PAF AT activity in the presence of EDTA, in the presence of Ca2+ 0.000104 |
704418 |
| 2.3.1.67 | 0.000104 |
- |
spleen, Ca2+ independent lyso-PAF AT activity in the presence of EDTA, in the presence of Ca2+ 0.000470 |
704418 |
| 2.3.1.67 | 0.0002 |
- |
kidney cortex |
487379 |
